Although each individual study above had a relatively small number of patients with eye disease in each cohort the consistent finding of a statistically significantly increasing serum or plasma level of VEGF with increasing disease severity was notable; making it a potentially viable clinical marker for DR presence and severity. This evidence concerns the gene VEGFA and eye disorder.